DISCLAIMER: PF-ILD accompanying exposure to the environment belongs to the infectious respiratory digestive and endocrine domain. DISCLAIMER: DISCLAIMER: DISCLAIMER: DISCLAIMER: PF-ILD accompanying exposure to the environment belongs to the infectious respiratory digestive and endocrine domain. Clinical performance is complex and often involves multi-systemic burden.
Early identification and normalisation of the diagnosis is essential for improving the prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of PF-ILD accompanying exposure to the environment require individualized development, usually including multidimensional management, including drug therapy, rehabilitation, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes based on disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of environmental exposure to PF-ILD. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.